Hong Kong · Delayed Price · Currency is HKD Hua Medicine (Shanghai) Statistics
Total Valuation
HKG:2552 has a market cap or net worth of HKD 2.23 billion. The enterprise value is 1.40 billion.
| Market Cap | 2.23B |
| Enterprise Value | 1.40B |
Important Dates
The next estimated earnings date is Friday, November 20, 2026.
| Earnings Date | Nov 20, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
HKG:2552 has 998.63 million shares outstanding. The number of shares has increased by 0.76% in one year.
| Current Share Class | 998.63M |
| Shares Outstanding | 998.63M |
| Shares Change (YoY) | +0.76% |
| Shares Change (QoQ) | -1.81% |
| Owned by Insiders (%) | 5.57% |
| Owned by Institutions (%) | 1.08% |
| Float | 662.67M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 2.95 |
| PB Ratio | 1.94 |
| P/TBV Ratio | 1.99 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 1.85 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 3.34, with a Debt / Equity ratio of 0.36.
| Current Ratio | 3.34 |
| Quick Ratio | 3.05 |
| Debt / Equity | 0.36 |
| Debt / EBITDA | n/a |
| Debt / FCF | -9.90 |
| Interest Coverage | -12.42 |
Financial Efficiency
Return on equity (ROE) is -10.51% and return on invested capital (ROIC) is -4.96%.
| Return on Equity (ROE) | -10.51% |
| Return on Assets (ROA) | -4.53% |
| Return on Invested Capital (ROIC) | -4.96% |
| Return on Capital Employed (ROCE) | -9.56% |
| Weighted Average Cost of Capital (WACC) | 7.64% |
| Revenue Per Employee | 1.78M |
| Profits Per Employee | -293,486 |
| Employee Count | 424 |
| Asset Turnover | 0.45 |
| Inventory Turnover | 2.12 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -53.93% in the last 52 weeks. The beta is 0.81, so HKG:2552's price volatility has been lower than the market average.
| Beta (5Y) | 0.81 |
| 52-Week Price Change | -53.93% |
| 50-Day Moving Average | 2.44 |
| 200-Day Moving Average | 2.87 |
| Relative Strength Index (RSI) | 39.45 |
| Average Volume (20 Days) | 996,650 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HKG:2552 had revenue of HKD 755.49 million and -124.44 million in losses. Loss per share was -0.13.
| Revenue | 755.49M |
| Gross Profit | 458.15M |
| Operating Income | -122.70M |
| Pretax Income | -124.44M |
| Net Income | -124.44M |
| EBITDA | -112.18M |
| EBIT | -122.70M |
| Loss Per Share | -0.13 |
Balance Sheet
The company has 1.24 billion in cash and 408.98 million in debt, with a net cash position of 829.69 million or 0.83 per share.
| Cash & Cash Equivalents | 1.24B |
| Total Debt | 408.98M |
| Net Cash | 829.69M |
| Net Cash Per Share | 0.83 |
| Equity (Book Value) | 1.15B |
| Book Value Per Share | 1.15 |
| Working Capital | 1.09B |
Cash Flow
In the last 12 months, operating cash flow was -35.25 million and capital expenditures -6.06 million, giving a free cash flow of -41.30 million.
| Operating Cash Flow | -35.25M |
| Capital Expenditures | -6.06M |
| Depreciation & Amortization | 10.69M |
| Net Borrowing | 88.26M |
| Free Cash Flow | -41.30M |
| FCF Per Share | -0.04 |
Margins
Gross margin is 60.64%, with operating and profit margins of -16.24% and -16.47%.
| Gross Margin | 60.64% |
| Operating Margin | -16.24% |
| Pretax Margin | -16.47% |
| Profit Margin | -16.47% |
| EBITDA Margin | -14.85% |
| EBIT Margin | -16.24% |
| FCF Margin | n/a |
Dividends & Yields
HKG:2552 does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| FCF Payout Ratio | n/a |
| Buyback Yield | -0.76% |
| Shareholder Yield | -0.76% |
| Earnings Yield | -5.59% |
| FCF Yield | -1.85% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Analyst Forecast
The average price target for HKG:2552 is 4.52, which is 102.69% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | 4.52 |
| Price Target Difference | 102.69% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 2 |
| Revenue Growth Forecast (3Y) | 54.02% |
| EPS Growth Forecast (3Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
HKG:2552 has an Altman Z-Score of -0.52 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.52 |
| Piotroski F-Score | 4 |